Pelthos Therapeutics Inc. (PTHS)

Pelthos Therapeutics Inc. (PTHS) is a Biotechnology company in the Healthcare sector listed on the AMEX.

As of Oct 23, 2026: market cap $85M; returns 1 day -13.2%, 1 week -15.6%, 1 year -50.9%.

Pelthos Therapeutics Inc. is a specialty biopharmaceutical company focused on acquiring, developing, and commercializing innovative therapies for skin conditions. The company's business model centers on commercializing FDA-approved dermatology products rather than early-stage research.

Groups PTHS belongs to

• Dermatology
• Biopharmaceutical
• Commercial Stage
• Healthcare
• Pharmaceuticals
• Commercial Stage Biotech
• Biotechnology
• Infectious Diseases

PTHS financial model: income statement, cash flow and balance sheet